This is (supposed to be) a reflective diary by a (not very) anonymous biomedical scientist who works somewhere in the south of England.
One day this diary may well be submitted to the Health and Care Professions Council as evidence of ongoing continual professional development....
Video: Asciminib vs. Bosutinib in Chronic Myeloid Leukemia Andreas Hochhaus, MD,
discusses results from a phase I study suggesting asciminib may have
superior efficacy to bosutinib in patients with heavily pretreated
chronic myeloid leukemia.
No comments:
Post a Comment